Clatterbridge research features on TV News

Posted 5th July 2022

The Clatterbridge Cancer Centre has been featured in a TV news report looking at vaccines for cancer.

Sky News visited Clatterbridge Cancer Centre – Liverpool (CCC-L) to film head and neck cancer patient Brian Wright and his consultant, Professor Christian Ottensmeier.

Brian is on the Transgene clinical trial which involves the trials team injecting him with a therapy tailor-made to his personal DNA, designed to help his own immune system ward off cancer permanently.

In February, CCC-L was the first hospital in the UK to give the treatment and since then a number of other patients have joined the clinical research trial, led by Prof Ottensmeier, Clatterbridge’s Director of Clinical Research and Professor of Immuno-Oncology at the University of Liverpool.

The therapy could benefit these patients greatly, as well as expanding the team’s knowledge of personalised cancer therapies that could eventually help people with other cancer types.

The Clinical Trails team facilitated the filming, and you can watch the report on Sky TV’s YouTube channel here: https://www.youtube.com/watch?v=0KO94fomo5Q

You can read a website article on his from Sky News here: https://news.sky.com/story/personalised-cancer-vaccine-trials-produce-really-hopeful-results-12645491

Pictured is patient Brian Wright being interviewed by Sky Science Correspondent Thomas Moore.